← board
PRGO
distress 0/10 · well-funded / low risk$10.12-3%today-64% from 52w high
Revenue
$969M
Liquidity
$357M
Runway
—
Shares 1y
+1%
Price & events
-29.6% over 6M
CatalystRating changeDilutionFinancingdashed = today
-3.4%
1D
-9.4%
1W
+6.6%
1M
-11.2%
3M
-27.9%
6M
-61.8%
1Y
-59.9%
2Y
-73.5%
5Y
-72.2%
All
Overview
- Market Cap
- $1.40B
- Enterprise Value
- $4.66B
- Volume
- 86.79K
- 52 Week Range
- $9.25 – $28.43
- Total Shares
- 138.37M
- Float Shares
- 137.64M
- Short %
- 27.28%
- % Held by Insiders
- 0.40%
- % Held by Institutions
- 116.73%
- RVOL
- 0.02x
- Beta
- 0.52
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 3
- 2026-08-05Estimated 45%earningsEarningsEarnings releaseyahoo
- 2025-07-13partnershipPerrigo agrees to sell Dermacosmetics Business to KKR vehicle for €300M plus earnout.SEC 8-K
- 2024-08-06safety signalStore brand Premium Infant Formula with Iron Milk-Based Powder · Voluntary recall of three lots of infant formula at retailer and warehouse level, shipped to CVS and H-E-B.SEC 8-K
Approved drugs (1)
- LORATADINELORATADINE2004 · Discontinued
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- 2026-02-27Canaccord GenuityBuy
- 2025-12-15JP MorganNeutral
- 2025-11-06Canaccord GenuityBuy
- 2025-11-06JP MorganOverweight → Neutral
- 2025-10-27JefferiesHold
- 2025-08-07Canaccord GenuityBuy
Competitors
- none identified
Recent news
- 2026-07-22Perrigo Plans Q2 Call for Aug. 5 at 8:30 a.m. - Stock Titan
- 2026-07-21Perrigo Co. PLC stock underperforms Tuesday when compared to competitors - MarketWatch
- 2026-07-20Perrigo Co. PLC stock outperforms competitors despite losses on the day - MarketWatch
- 2026-07-20ETFs Investing in Perrigo Co. Plc Stocks - TradingView
- 2026-07-17Perrigo Co. PLC stock underperforms Friday when compared to competitors - MarketWatch
- 2026-07-16Perrigo Co. PLC stock outperforms competitors on strong trading day - MarketWatch
- 2026-07-15Perrigo Co. PLC stock outperforms competitors on strong trading day - MarketWatch
- 2026-07-15Perrigo (NYSE: PRGO) awards 14,964 RSUs to director Ahmed Salman Amin - Stock Titan
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.